Abstract
Editorial: Combination Strategies in the Treatment of Melanoma.
Highlights
Specialty section: This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology
The advent of immune checkpoint inhibition has led to a better understanding of the possible effects of immunotherapy on immune-mediated vasculopathy in the tumor, with the suggestion that the tumor vasculature may be an important interface between the tumor-directed immune response and the cancer itself
The rationale for combined angiogenesis inhibition and immune checkpoint inhibition is reviewed by Ott et al Clinical studies of combined immunotherapy and vascular endothelial growth factor (VEGF) inhibition, e.g., ipilimumab plus bevacizumab, are ongoing and represent a potentially promising approach for cancer treatment
Summary
Specialty section: This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology. The Editorial on the Research Topic Combination Strategies in the Treatment of Melanoma
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
